Analysts Set Repligen Co. (NASDAQ:RGEN) Target Price at $181.00
Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target among brokers […]
Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target among brokers […]
